News About: Pharm. Industry
Celltrion investing funds into Operation Chromite
As a movie that Celltrion invested KRW 3 billion into, ‘Operation Chromite,’ recorded 5.2 million audiences in 12 days after its release, the Celltrion’s investment returns and promotional effect have attracted attent...
High influence of Korean biosimilars, raising expectations
The 3 Korean biosimilars that are currently sold in Europe have been evaluated so positively that market shares of the original products are decreasing. This is why there are high expectations on biosimilars and biobe...
Domestic companies’ strategy to avoid ‘Pradaxa’ patent
Domestic pharmaceutical companies are altering strategies on patent suits to develop generics of ‘Pradaxa(generic name: dabigatran).’
As keeping losing on its substance and composition patent nullification trials, th...
This year’s pharmaceutical export goal to be set at USD 6.42 billion
With domestic pharmaceutical companies’ aggressive pioneering to foreign markets, this year’s foreign pharmaceutical exports will hit USD 6.418 billion, expected to grow 10% up compared to the last year.
The Korea Ph...
160 pharmaceutical companies from 19 countries share technology
The opening ceremony of an international pharmaceutical event, CPhI, is coming up in 3 weeks.
‘CPhI Korea 2016,’ which will be held at the D Hall of Seoul COEX from the 23rd(TUE) to 25th(THU) of August, is jointly h...
‘Rebate’ a way for patent-expired original products to survive
Ethicality of large global companies branched in Korea has been severely damaged after the Oxy’s humidifier disinfectant crisis and the Novartis’ rebate crisis.
Most of all, since multinational pharmaceutical compan...
Kolmar Korea & Abbott Korea sign exclusive license of 2 CNS drugsOn the 27th, Kolmar Korea(President Dong-han Yoon) announced the company concluded an CMO(contract manufacturing organization) agreement of 2 types of central nervous system(CNS...
|
Pharmaceutical MRs, “Doctors won’t let us meet unless paying medical fees”
“I have no time. Pay the fees to see me.”
The sales tradition of the pharmaceutical field is getting merciless.
Since an endless number of rebate investigations and scandals have been exposed, doctors have shown co...
What has changed in 4 years after ‘Pharma Korea 2020’ announcement
The Korean pharmaceutical industry has met the 4-year anniversary of announcing the ‘Pharma Korea 2020’ vision on the 26th.
At the ‘2020 Vision and Roadmap Conference of Korea’s Pharmaceutical Industry’ jointly held ...
Multinational pharma companies’ entertainment expenses increased by 8% last year
It was observed major multinational pharmaceutical companies’ entertainment expenses was increased by more than 8% last year. They seem to show contrary to domestic pharmaceutical companies trying to cut entertainment...
